These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15279601)

  • 1. "Dipeptoids": from the chemical structure of the endogenous peptide to the design of peptidomimetics.
    Martín-Martínez M; Patiño-Molina R; García-López MT; González-Muñiz R
    Mini Rev Med Chem; 2004 Aug; 4(6):669-80. PubMed ID: 15279601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists.
    Martín-Martínez M; De La Figuera N; Latorre M; Herranz R; García-López MT; Cenarruzabeitia E; Del Río J; González-Muñiz R
    J Med Chem; 2000 Oct; 43(20):3770-7. PubMed ID: 11020292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of CCK-B antagonists.
    Horwell DC
    Neuropeptides; 1991 Jul; 19 Suppl():57-64. PubMed ID: 1881533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
    Ding XQ; Chen D; Håkanson R
    Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for design of non peptide CCK1R agonist/antagonist ligands.
    García-López MT; González-Muñiz R; Martín-Martínez M; Herranz R
    Curr Top Med Chem; 2007; 7(12):1180-94. PubMed ID: 17584140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.
    Bellier B; McCort-Tranchepain I; Ducos B; Danascimento S; Meudal H; Noble F; Garbay C; Roques BP
    J Med Chem; 1997 Nov; 40(24):3947-56. PubMed ID: 9397175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure activity of C-terminal modified analogs of Ac-CCK-7.
    Tilley JW; Danho W; Shiuey SJ; Kulesha I; Sarabu R; Swistok J; Makofske R; Olson GL; Chiang E; Rusiecki VK
    Int J Pept Protein Res; 1992 Apr; 39(4):322-36. PubMed ID: 1385345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.
    Low CM; Black JW; Broughton HB; Buck IM; Davies JM; Dunstone DJ; Hull RA; Kalindjian SB; McDonald IM; Pether MJ; Shankley NP; Steel KI
    J Med Chem; 2000 Sep; 43(19):3505-17. PubMed ID: 11000005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct identification of the agonist binding site in the human brain cholecystokininB receptor.
    Anders J; Blüggel M; Meyer HE; Kühne R; ter Laak AM; Kojro E; Fahrenholz F
    Biochemistry; 1999 May; 38(19):6043-55. PubMed ID: 10320330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.
    Bellier B; Da Nascimento S; Meudal H; Gincel E; Roques BP; Garbay C
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1419-24. PubMed ID: 9871777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence studies on the binding between 1-47 fragment of cholecystokinin receptor CCK(A)-R(1-47) and nonsulfated cholecystokinin octapeptide CCK8.
    Ragone R; De Luca S; Tesauro D; Pedone C; Morelli G
    Biopolymers; 2000-2001; 56(1):47-53. PubMed ID: 11582577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.
    Martín-Martínez M; Bartolomé-Nebreda JM; Gómez-Monterrey I; González-Muñiz R; García-López MT; Ballaz S; Barber A; Fortuño A; Del Río J; Herranz R
    J Med Chem; 1997 Oct; 40(21):3402-7. PubMed ID: 9341915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR studies of CCK-8/CCK1 complex support membrane-associated pathway for ligand-receptor interaction.
    Giragossian C; Pellegrini M; Mierke DF
    Can J Physiol Pharmacol; 2002 May; 80(5):383-7. PubMed ID: 12056543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor.
    Giragossian C; Mierke DF
    Biochemistry; 2001 Apr; 40(13):3804-9. PubMed ID: 11300760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
    De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
    ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly constrained dipeptoid analogues containing a type II' beta-turn mimic as novel and selective CCK-A receptor ligands.
    de la Figuera N; Martín-Martínez M; Herranz R; García-López MT; Latorre M; Cenarruzabeitia E; del Río J; González-Muñiz R
    Bioorg Med Chem Lett; 1999 Jan; 9(1):43-8. PubMed ID: 9990454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity.
    Ren Y; Bläker M; Seshadri L; McBride EW; Beinborn M; Kopin AS
    J Mol Neurosci; 2003 Apr; 20(2):115-24. PubMed ID: 12794305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the chemical structure of peptides as the starting point to design nonpeptide agonists and antagonists at peptide receptors: examples with cholecystokinin and tachykinins.
    Horwell DC
    Bioorg Med Chem; 1996 Oct; 4(10):1573-6. PubMed ID: 8931926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermolecular interactions between peptidic and nonpeptidic agonists and the third extracellular loop of the cholecystokinin 1 receptor.
    Giragossian C; Sugg EE; Szewczyk JR; Mierke DF
    J Med Chem; 2003 Jul; 46(16):3476-82. PubMed ID: 12877585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.